Research Article
Preparation, Characterization, and In Vivo Evaluation of Olanzapine Poly(D,L-lactide-co-glycolide) Microspheres
Figure 2
In vivo release of Olanzapine PLGA microspheres (Formulations A and B = 10 mg/kg dose, and Formulations C and D = 20 mg/kg dose).
